Physician profile
Damion A Martins
NPI 1114954534
$3,044.31
in general payments reported to CMS, 2019-2025
24 companies · $787 in 2025
The $787 reported for 2025 was more than what 90% of Sports Medicine (Internal Medicine) providers received nationally (typical 2025 total: $99.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $300 · 2021: $186 · 2022: $266 · 2023: $514 · 2024: $653 · 2025: $787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,953.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $630.97 | 2019-2025 | Durolane, Durolane, Xcell |
| Ferring Pharmaceuticals INC. | $581.77 | 2019-2025 | Euflexxa |
| Ossur Americas, INC. | $312.99 | 2024-2025 | Miami J, Unloader One X |
| Depuy Synthes Sales INC. | $248.67 | 2019-2025 | Monovisc, Orthovisc |
| Stryker Corporation | $232.76 | 2021-2023 | Na |
| Novo Nordisk INC | $223.68 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Centinel Spine, LLC | $180.06 | 2020 | |
| Pacira Therapeutics, INC. | $108.34 | 2019-2021 | |
| Lilly USA, LLC | $78.78 | 2022-2025 | Zepbound, Jardiance |
| Kowa Pharmaceuticals America, INC. | $63.99 | 2022-2023 | Seglentis |
| Smith+Nephew, INC. | $44.79 | 2023 | Bone Anchors With Arthroscopic Delivery System |
| Pacira Pharmaceuticals Incorporated | $43.53 | 2022-2024 | Exparel, Zilretta, Iovera |
| Endo Pharmaceuticals INC. | $42.53 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $35.54 | 2023-2025 | Strensiq |
| Abbott Laboratories | $32.46 | 2024 | Eterna |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $32.30 | 2023 | |
| Dexcom, INC. | $31.98 | 2023 | Dexcom G6 Transmitter |
| Baxter Healthcare | $25.58 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Pfizer INC. | $16.87 | 2025 | |
| Halozyme INC | $16.79 | 2023 | |
| Sanofi-Aventis U.S. LLC | $15.88 | 2022 | |
| Horizon Therapeutics Plc | $14.92 | 2020 | |
| Carestream Health, INC. | $14.57 | 2019 | |
| Fidia Pharma USA INC. | $14.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Damion Martins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.